GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1415
Enrollment
INDUSTRY
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Intravenous GR270773- Phospholipid Emulsion
OTHER:
Placebo
Sponsor
GlaxoSmithKline